Shaking Up the Team: INVO Fertility's New Leadership Moves
INVO Fertility, a company focused on fertility clinics and related technologies, is reshuffling its top executives to better support its growth plans.
Leadership Shifts
- Terah Krigsvold, who has been with INVO since 2020, is stepping up to become the new Chief Financial Officer (CFO). This role was previously held by Andrea Goren.
- Andrea Goren is now taking on a new challenge as the Chief Business Officer and CEO of INVO Centers LLC, a subsidiary focused on fertility clinics.
CEO's Perspective
The company's CEO, Steve Shum, explained that these changes are meant to strengthen INVO's ability to grow and become profitable. He praised:
- Terah's progress
- Andrea's experience in handling major financing and acquisition deals.
INVO Fertility's Mission
INVO Fertility is dedicated to making fertility treatments more accessible. They run clinics that offer a unique procedure called intravaginal culture (IVC), which uses a special device called INVOcell. This method allows:
- Fertilization
- Early embryo development
to happen inside the woman's body, making the process more affordable and intimate compared to traditional IVF treatments.
Expansion and Reach
The company also sells the INVOcell device to other fertility clinics. With:
- Two operational INVO Centers
- One IVF clinic in the U.S.
INVO is expanding its reach in the fertility sector.
Risks and Uncertainties
It's important to note that the company's plans include some risks and uncertainties. Factors like:
- Market conditions
- Regulatory changes
could affect INVO's ability to achieve its goals.
For More Information
For more information, you can:
- Visit INVO Fertility's website
- Reach out to their investor contacts.
